| Literature DB >> 30915949 |
Brady A'Hearn-Thomas1, Ameneh Khatami2,3, Tara M Randis2,3, Moses Vurayai4, Margaret Mokomane4, Tonya Arscott-Mills5,6, Francis M Banda5, Tiny Mazhani5, Thabo Lepere7, Ponatshego Gaolebale8, Seeletso Nchingane8, Anna Chamby2,3, Margaret Gegick2,3, Evan Suzman2,3, Andrew P Steenhoff9,5,6, Adam J Ratner2,3.
Abstract
Maternal rectovaginal colonization is the major risk factor for early-onset neonatal sepsis due to Group B Streptococcus (GBS), a major cause of early life morbidity and mortality. Transmission generally occurs perinatally from colonized mothers to infants. Vaccines targeting a subset of GBS serotypes are under development, but GBS epidemiology remains poorly understood in many African nations. We performed a cross-sectional study of GBS colonization among pregnant women at two sites in Botswana, a country with minimal prior GBS carriage data. We found a rectovaginal colonization rate of 19%, comparable with studies in other regions; however, we also noted a striking predominance of serotype V (> 45% of strains). Although further studies are required to delineate the burden of invasive GBS disease in Botswana and the generalizability of type V epidemiology, these data provide a useful baseline for understanding the potential local impact of GBS prevention strategies, including vaccines.Entities:
Mesh:
Year: 2019 PMID: 30915949 PMCID: PMC6493924 DOI: 10.4269/ajtmh.18-0847
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345